Intra-Cellular Therapies Statistics
Total Valuation
BOM:544321 has a market cap or net worth of INR 172.74 billion. The enterprise value is 205.95 billion.
Market Cap | 172.74B |
Enterprise Value | 205.95B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 233.54M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +11.10% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 25.73M |
Valuation Ratios
The trailing PE ratio is 104.64 and the forward PE ratio is 53.46.
PE Ratio | 104.64 |
Forward PE | 53.46 |
PS Ratio | 10.70 |
PB Ratio | 2.92 |
P/TBV Ratio | 5.42 |
P/FCF Ratio | 27.77 |
P/OCF Ratio | 25.50 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.19, with an EV/FCF ratio of 33.11.
EV / Earnings | 124.76 |
EV / Sales | 12.76 |
EV / EBITDA | 27.19 |
EV / EBIT | 41.10 |
EV / FCF | 33.11 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.46.
Current Ratio | 1.57 |
Quick Ratio | 1.02 |
Debt / Equity | 0.46 |
Debt / EBITDA | 3.55 |
Debt / FCF | 4.41 |
Interest Coverage | 1.99 |
Financial Efficiency
Return on equity (ROE) is 5.29% and return on invested capital (ROIC) is 6.84%.
Return on Equity (ROE) | 5.29% |
Return on Assets (ROA) | 5.99% |
Return on Invested Capital (ROIC) | 6.84% |
Return on Capital Employed (ROCE) | 5.63% |
Revenue Per Employee | 5.27M |
Profits Per Employee | 539,278 |
Employee Count | 3,061 |
Asset Turnover | 0.30 |
Inventory Turnover | 13.12 |
Taxes
In the past 12 months, BOM:544321 has paid 1.29 billion in taxes.
Income Tax | 1.29B |
Effective Tax Rate | 43.79% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 745.45 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 43.20 |
Average Volume (20 Days) | 7,166 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544321 had revenue of INR 16.14 billion and earned 1.65 billion in profits. Earnings per share was 9.37.
Revenue | 16.14B |
Gross Profit | 12.32B |
Operating Income | 5.17B |
Pretax Income | 2.94B |
Net Income | 1.65B |
EBITDA | 7.49B |
EBIT | 5.17B |
Earnings Per Share (EPS) | 9.37 |
Balance Sheet
The company has 5.22 billion in cash and 27.44 billion in debt, giving a net cash position of -22.21 billion.
Cash & Cash Equivalents | 5.22B |
Total Debt | 27.44B |
Net Cash | -22.21B |
Net Cash Per Share | n/a |
Equity (Book Value) | 59.06B |
Book Value Per Share | 205.81 |
Working Capital | 3.74B |
Cash Flow
In the last 12 months, operating cash flow was 6.77 billion and capital expenditures -554.09 million, giving a free cash flow of 6.22 billion.
Operating Cash Flow | 6.77B |
Capital Expenditures | -554.09M |
Free Cash Flow | 6.22B |
FCF Per Share | n/a |
Margins
Gross margin is 76.30%, with operating and profit margins of 32.03% and 10.23%.
Gross Margin | 76.30% |
Operating Margin | 32.03% |
Pretax Margin | 18.20% |
Profit Margin | 10.23% |
EBITDA Margin | 46.43% |
EBIT Margin | 32.03% |
FCF Margin | 38.54% |
Dividends & Yields
BOM:544321 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.96% |
FCF Yield | 3.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BOM:544321 has an Altman Z-Score of 2.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.87 |
Piotroski F-Score | 4 |